Roundtable: Outlining Model Validation & Establishing the Need for Standardization

Time: 9:15 am
day: Day Two


  • How to effectively identify novel drug combinations on a limited experimental budget
  • Common pitfalls in phenotypic drug combination screening analysis – can we move away from computed synergy scores
  • Avoiding bias when evaluating drug combinations in vivo